This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Olon S.p.a.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lodigiano, IT (2019)
- Casaletto Lodigiano, IT (2022)
Company Filing History:
Years Active: 2019-2022
Title: Marco Quaroni: Innovator in Pharmaceutical Processes
Introduction
Marco Quaroni is a notable inventor based in Casaletto Lodigiano, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of crisaborole, a medication used for treating certain skin conditions. With a total of 2 patents to his name, Quaroni's work exemplifies innovation in drug formulation.
Latest Patents
Quaroni's latest patents include a process for the preparation of crisaborole in a stable crystal form. This invention focuses on the efficient synthesis of crisaborole, ensuring its stability and efficacy. Additionally, he has developed another process for the preparation of crisaborole, further enhancing the methods available for producing this important pharmaceutical compound.
Career Highlights
Marco Quaroni is currently employed at Olon S.p.a., a company known for its commitment to pharmaceutical development and manufacturing. His role at Olon S.p.a. allows him to apply his expertise in innovative processes that contribute to the advancement of medical treatments.
Collaborations
Throughout his career, Quaroni has collaborated with talented professionals, including Federico Gassa and Lazzaro Feliciani. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Marco Quaroni's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an innovator. His work continues to impact the industry positively, paving the way for advancements in drug formulation and stability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile